Global Transfection Technologies Market Insights, Revenue Analysis, and Future Outlook | Valuates Reports


 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Expected Market Growth Rate for the Trastuzumab Biosimilars Market?
The transfection technologies market size has grown strongly in recent years. It will grow from $1.31 billion in 2025 to $1.42 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to growth in molecular biology research, advances in gene expression studies, expansion of protein production needs, increased funding for genomics research, early adoption in academic laboratories.

The transfection technologies market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growth of cell and gene therapies, increasing rna therapeutics pipelines, rising investment in life sciences research, demand for efficient transfection reagents, expansion of personalized medicine. Major trends in the forecast period include rising demand for gene editing research tools, expansion of rna-based therapeutics development, increasing use in cell and gene therapy, growth in academic and biomedical research, advancement in non-viral transfection methods.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

What Are the Key Factors Contributing to Transfection Technologies Market Growth?
The rise in gene therapy is expected to propel the growth of the transfection technologies market going forward. Gene therapy is a technique that aims to treat or prevent diseases by modifying genes, which includes inserting, repairing, or replacing faulty genes. Gene therapy's rise is driven by progress in genetic research, enhanced delivery methods, and its ability to treat previously incurable genetic conditions. Transfection technologies are crucial for gene therapy, facilitating the precise, safe, and effective delivery of genetic material into cells. They support both temporary and permanent genome modifications, essential for treating genetic diseases and cancers. For instance, in December 2024, according to American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the rise in gene therapy is driving the growth of the transfection technologies market.

What Are the Key Segments in the Transfection Technologies Market?
The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

What Are the Top Trends Expected to Shape the Transfection Technologies Market by 2029?
Major companies in the transfection technologies market are focused on developing advanced technology, such as mechanoporation transfection systems, to enable more complex and personalized applications in research and therapeutics. Mechanoporation transfection systems use mechanical forces to create temporary pores in cell membranes, allowing genetic material to enter cells. This method is efficient and minimally invasive, preserving better cell viability. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system includes a benchtop unit and the CellPore Transfection Kit 300, which comes with a specialized reagent kit and single-use delivery cartridges. Using controlled, rapid deformation in microfluidic channels, CellPore efficiently introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cell disruption and high viability. These features are critical for advancing research and the development of cutting-edge cell and gene therapies.

Which Companies Hold the Largest Share in the Transfection Technologies Market?
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Get the full transfection technologies market report here:
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

How Does Transfection Technologies Market Growth Vary Across Major Regions?
North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Popular posts from this blog

Thrombosis And Hemostasis Biomarkers Industry Projected to Experience Accelerated Growth by 2030

Viral Vector Production (Research-Use) Industry Forecasted for Rapid Expansion, Reaching $3.56 Billion by 2030

Trastuzumab Biosimilars Industry Revenue to Reach $24.48 Billion by 2030 with CAGR of 28.9% (2026-2030)